Split Rock Private Trading & Wealth Management
ELDN icon

Split Rock Private Trading & Wealth Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Split Rock Private Trading & Wealth Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.3K Hold
10,000
– – 0.02% 50
2026
Q2 		$39.4K Hold
10,000
– – 0.03% 49
2026
Q1 		$30.8K Hold
10,000
– – 0.02% 46
2025
Q4 		$15.1K Buy
+10,000
New +$23.8K 0.01% 36

Other funds holding ELDN

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
AIC
AWM Investment Company New York $1.04B AUM 103.31% 1-Year Est. Return
22NW LP
22NW LP Seattle, Washington $144M AUM 2.58% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Blue Owl Capital Holdings
Blue Owl Capital Holdings New York $548M AUM 35.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Split Rock Private Trading & Wealth Management's ELDN Position: Q3 2026 in Review

Split Rock Private Trading & Wealth Management held its Eledon Pharmaceuticals (ELDN) position steady in Q3 2026 at 10,000 shares worth $25.3K. The position accounts for 0.02% of the portfolio, ranked #50.

Split Rock Private Trading & Wealth Management first reported a position in ELDN in Q4 2025 and has held it in 4 quarters since. The position peaked at $39.4K in Q2 2026. 114 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.

  • Split Rock Private Trading & Wealth Management held 10,000 shares of Eledon Pharmaceuticals worth $25.3K as of Q3 2026.
  • Split Rock Private Trading & Wealth Management left its Eledon Pharmaceuticals share count unchanged in Q3 2026.
  • Eledon Pharmaceuticals made up 0.02% of Split Rock Private Trading & Wealth Management's portfolio in Q3 2026, its #50 holding.
  • Split Rock Private Trading & Wealth Management first reported a position in Eledon Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Split Rock Private Trading & Wealth Management's Eledon Pharmaceuticals position peaked at $39.4K in Q2 2026.
  • 114 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.

Based on Split Rock Private Trading & Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.